Jump to section
To tackle the obesity epidemic.
Sticking to diets and exercise regimes is tough - we all make that New Year’s resolution, but less than a third of us actually follow through. Signos sets out to make it easier with its real-time glucose monitoring to help you see how food, exercise and more is affecting your body.
What’s unique about its package is the CGM (Continuous Glucose Monitor), a small wearable patch to put on your arm, which connects to an app that displays your glucose levels at all times. Input what you’re eating into the platform, and it starts to build a picture of how different foods affect you personally.
The device lasts 10 days before it has to be disposed of and replaced, and Founder Fouladgar-Mercer admits that it isn’t the most environmentally-friendly model. But, it’s an original idea and sticks out in the market as the first company to be able to provide CGMs without a doctor’s prescription (they have previously just been used for diabetics), even if it may have to fight to prove this in the context of a world increasingly concerned with sustainability and body positivity.
Freddie
Company Specialist at Welcome to the Jungle
Oct 2023
$20m
SERIES B
Nov 2021
$13m
SERIES A
This company has top investors
A former associate at JP Morgan, they have sat on the board of Makara and TouchCommerce. They are still a board member at Onclusive - which they founded and are the former CEO of - as well holding advisory roles at Correlation Ventures and Clearco.
Pierre Wehbe
(Chief Architect)Previously co-founded European Innovation Academy and Sfearia, as well as working as a Software Engineer at Atheer.
Bill Tancer
(Chief Data Officer)Previously worked as a Prosecuting Attorney within the US Navy Reserves, as Director of Market Research at LookSmart, Director of Corporate Strategy at Zaplet, SVP of Global Research at Experian and Principal at Tancer Advisory Services. They've also published two books about business, one a NYT Bestseller, and still work as an Advisor at Onclusive.